ISIN | LU0549584471 |
---|---|
Valor Number | 11846194 |
Bloomberg Global ID | UBSOPIA LX |
Fund Name | UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) I-A1-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This actively managed sub-fund predominantly invests in equities, equity rights or other equity interests in companies domiciled or chiefly active in Europe. The UBS ESG consensus score is used to identify issuers/companies for the investment universe with strong environmental and social performance characteristics, or a strong sustainability profile. |
Peculiarities |
Current Price * | 230.38 EUR | 23.04.2025 |
---|---|---|
Previous Price * | 226.19 EUR | 22.04.2025 |
52 Week High * | 252.61 EUR | 03.03.2025 |
52 Week Low * | 210.66 EUR | 09.04.2025 |
NAV * | 230.38 EUR | 23.04.2025 |
Issue Price * | 230.38 EUR | 23.04.2025 |
Redemption Price * | 230.38 EUR | 23.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 386,299,911 | |
Unit/Share Assets *** | 486,268 | |
Trading Information SIX |
YTD Performance | +1.20% |
31.12.2024 - 23.04.2025
31.12.2024 23.04.2025 |
---|---|---|
YTD Performance (in CHF) | +0.82% |
31.12.2024 - 23.04.2025
31.12.2024 23.04.2025 |
1 month | -5.21% |
24.03.2025 - 23.04.2025
24.03.2025 23.04.2025 |
3 months | -3.59% |
23.01.2025 - 23.04.2025
23.01.2025 23.04.2025 |
6 months | -2.09% |
23.10.2024 - 23.04.2025
23.10.2024 23.04.2025 |
1 year | +0.10% |
23.04.2024 - 23.04.2025
23.04.2024 23.04.2025 |
2 years | +6.12% |
24.04.2023 - 23.04.2025
24.04.2023 23.04.2025 |
3 years | +10.35% |
25.04.2022 - 23.04.2025
25.04.2022 23.04.2025 |
5 years | +47.35% |
23.04.2020 - 23.04.2025
23.04.2020 23.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 9.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 23.04.2025 |
AstraZeneca PLC | 4.62% | |
---|---|---|
ASML Holding NV | 4.18% | |
Shell PLC | 3.64% | |
Iberdrola SA | 3.63% | |
HSBC Holdings PLC | 3.31% | |
L'Oreal SA | 3.23% | |
Lvmh Moet Hennessy Louis Vuitton SE | 3.18% | |
Deutsche Telekom AG | 2.82% | |
Hannover Rueck SE Registered Shares | 2.82% | |
Legal & General Group PLC | 2.75% | |
Last data update | 31.03.2025 |
TER | 0.93% |
---|---|
TER date | 31.05.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.72% |
Ongoing Charges *** | 0.93% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |